1551 – 1560 of 1829
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Estimating the parameters of the operational model of pharmacological agonism
(
- Contribution to journal › Article
-
Mark
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
(
- Contribution to journal › Article
-
Mark
Non-Fluoroscopic Catheter-Based Mapping Systems in Cardiac Electrophysiology--from Approved Clinical Indications to Novel Research Usage.
(
- Contribution to journal › Article
-
Mark
Decision Support for the Initial Triage of Patients with Acute Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?
(
- Contribution to journal › Article
-
Mark
Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications
(
- Contribution to journal › Scientific review
-
Mark
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
(
- Contribution to journal › Article
-
Mark
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)
(
- Contribution to journal › Article
-
Mark
Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo.
(
- Contribution to journal › Article
-
Mark
Stroke prevention using the oral direct thrombin inhibitor ximelagatran inpatients with nonvalvular atrial fibrillation. Pooled analysis from the SPORTIF III ad V studies.
(
- Contribution to journal › Article